# GreenBone Ortho SRL

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/greenbone-ortho

- Industry: Medical Devices & Equipment
- Headquarters: Faenza, Italy
- Website: www.greenbone.it
- Total disclosed funding: $15M
- Latest round: Series B (Apr 12, 2021)
- Investors on record: 5

## About

GreenBone Ortho SRL is dedicated to advancing bone regeneration through innovative solutions, primarily offering its flagship product, b.Bone, which mimics human bone properties using biomimetic materials.Founded in 2014 in Faenza, Italy, GreenBone Ortho specializes in bone regeneration technology. The company has completed 3 funding deals, with its most recent being a SERIES B round on April 12, 2021, raising EUR 10.00 mn from investors including 3B Future Health Fund, CDP Venture Capital, Innogest, Italian Angels for Growth, and META Ventures. The company is led by CEO Stefano Di Lullo, while founders Elena Venturelli and Saverio Gellini have previously established other ventures in the healthcare sector.GreenBone Ortho specializes in innovative solutions for bone regeneration, primarily through its flagship product, b.Bone. This advanced bone substitute features a unique three-dimensional structure composed of biomimetic and bioactive materials derived from rattan wood, designed to closely mimic human bone properties. The technology enables the transformation of native vegetable structures into inorganic biomaterials, addressing critical clinical needs in areas such as traumatology, bone augmentation, deformity correction, bone lengthening, and the treatment of non-union and bone loss. The company's products are marketed primarily to surgeons and healthcare professionals, emphasizing their safe and biocompatible nature that makes them suitable for a diverse patient demographic. Geographically, GreenBone’s solutions are targeted at markets across Europe and potentially expanding into other regions where advanced orthopedic treatments are sought.In the most recent financial year of 2023, GreenBone Ortho reported a revenue of EUR 106,507.60, while also recording an EBITDA of EUR -4,192,963.50. The company operates a revenue model centered on direct sales to healthcare professionals and institutions utilizing its b.Bone products, facilitated through partnerships with hospitals and surgical centers.Following the EUR 10.00 mn raised in its SERIES B round in April 2021, GreenBone Ortho plans to utilize this funding to expand the clinical use of its innovative products, construct a new production line, and launch its approved product into the market. The company aims to broaden its reach into new geographic regions, with specific targets in Europe, while continuing to address the critical needs of bone regeneration within the healthcare landscape.

## Funding rounds

- Series B, Apr 12, 2021, $12M — CDP Venture Capital, Innogest, META Group, Italian Angels for Growth, 3B Future Health Fund
- Seed, Sep 18, 2015, $3.4M — META Group, Italian Angels for Growth

## Investors

- META Group (https://capitalatlas.ai/funds/meta-group) — Seed, Series B
- Italian Angels for Growth (https://capitalatlas.ai/funds/italian-angels-for-growth) — Seed, Series B
- CDP Venture Capital (https://capitalatlas.ai/funds/cdp-venture-capital) — Series B
- Innogest (https://capitalatlas.ai/funds/innogest) — Series B
- 3B Future Health Fund (https://capitalatlas.ai/funds/3b-future-health-fund) — Series B